1 the Relationship Between Vaccine Experience and Vaccine Harm
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Case 1:21-Cv-00756 ECF No. 1, Pageid.1 Filed 08/27/21 Page 1 of 49
Case 1:21-cv-00756 ECF No. 1, PageID.1 Filed 08/27/21 Page 1 of 49 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF MICHIGAN JEANNA NORRIS, on behalf of herself ) and all others similarly situated, ) ) Plaintiffs, ) ) v. ) ) CLASS ACTION COMPLAINT SAMUEL L. STANLEY, JR. ) FOR DECLARATORY AND in his official capacity as President of ) INJUNCTIVE RELIEF Michigan State University; DIANNE ) BYRUM, in her official capacity as Chair ) JURY TRIAL DEMANDED of the Board of Trustees, DAN KELLY, ) in his official capacity as Vice Chair ) of the Board of Trustees; and RENEE ) JEFFERSON, PAT O’KEEFE, ) BRIANNA T. SCOTT, KELLY TEBAY, ) and REMA VASSAR, in their official ) capacities as Members of the Board of ) Trustees of Michigan State University, ) and JOHN and JANE DOES 1-10, ) ) Defendants. ) Plaintiff and those similarly situated, by and through their attorneys at the New Civil Liberties Alliance (“NCLA”), hereby complains and alleges the following: INTRODUCTORY STATEMENT a. By the spring of 2020, the novel coronavirus SARS-CoV-2, which can cause the disease COVID-19, had spread across the globe. Since then, and because of the federal government’s “Operation Warp Speed,” three separate coronavirus vaccines have been developed and approved more swiftly than any other vaccines in our nation’s history. The Food and Drug Administration (“FDA”) issued an Emergency Use Authorization (“EUA”) for the Pfizer- 1 Case 1:21-cv-00756 ECF No. 1, PageID.2 Filed 08/27/21 Page 2 of 49 BioNTech COVID-19 Vaccine (“BioNTech Vaccine”) on December 11, 2020.1 Just one week later, FDA issued a second EUA for the Moderna COVID-19 Vaccine (“Moderna Vaccine”).2 FDA issued its most recent EUA for the Johnson & Johnson COVID-19 Vaccine (“Janssen Vaccine”) on February 27, 2021 (the only EUA for a single-shot vaccine).3 b. -
Antibody Response and Evaluation of Protection After Immunisation With
Aus dem Institut für Virologie der Tierärztlichen Hochschule Hannover Untersuchungen zur Wirksamkeitsprüfung und praktischen Anwendung von viralen Rinderimpstoffen [Investigations on the efficacy testing and practical application of viral cattle vaccines] Habilitationsschrift zur Erlangung der Venia legendi an der Tierärztlichen Hochschule Hannover Vorgelegt von Dr. med. vet. Birgit Makoschey Hannover 2009 Tag der nichtöffentlichen wissenschaftlichen Aussprache 15. Juni 2010 Table of contents Table of contents Table of contents.....................................................................................................................................3 Abbreviations..........................................................................................................................................4 List of used publications ........................................................................................................................6 A. Introduction...................................................................................................................................8 Vaccines in veterinary medicine.........................................................................................................8 Live attenuated vaccines .................................................................................................................8 Inactivated vaccines ........................................................................................................................9 Alternative approaches -
Vaccination As a Control Tool for Exotic Animal Diseases
www.defra.gov.uk Vaccination as a Control Tool for Exotic Animal Disease Key Considerations March 2010 Department for Environment, Food and Rural Affairs Nobel House 17 Smith Square London SW1P 3JR Tel: 020 7238 6000 Website: www.defra.gov.uk © Crown copyright 2010 Copyright in the typographical arrangement and design rests with the Crown. This publication (excluding the Royal Arms and departmental logos) may be re-used free of charge in any format or medium for research for non-commercial purposes, private study or for internal circulation within an organisation. This is subject to it being re-used accurately and not used in a misleading context. The material must be acknowledged as Crown copyright and the title of the publication specified. For any other use of this material please apply for a Click-Use PSI Licence or by writing to: Office of Public Sector Information Information Policy Team Kew Richmond Surrey TW9 4DU e-mail: [email protected] Information about this publication and copies are available from: Exotic Disease Policy Programme Defra Nobel House 17 Smith Square London SW1P 3JR This document is available on the Defra website: Published by the Department for Environment, Food and Rural Affairs Vaccination as a Control Tool for Exotic Animal Disease Key Considerations Introduction 4 Using Vaccination against an Exotic Animal Disease: Implications 5 and Considerations Veterinary and Technical Considerations 5 Whether vaccination is the most appropriate disease control tool 5 Box A: A disease for which vaccination is -
Film Flub; Diversity Deficiency
Spectrum | Autism Research News https://www.spectrumnews.org SPOTTED New numbers; film flub; diversity deficiency BY KATIE MOISSE 1 APRIL 2016 WEEK OF MARCH 28TH New numbers After ticking up since 2000, the rate of autism among 8-year-olds in the U.S. may be leveling off. One in 68 school-age children have autism, according to data released yesterday by the U.S. Centers for Disease Control and Prevention (CDC). The same rate was reported in 2014, marking a possible plateau in autism prevalence. The CDC cautions, however, that it’s too soon to tell whether the rate is truly stabilizing. Late last year, the agency reported that 1 in 45 children have autism, based on a different surveillance method. Prevalence also varies dramatically between states, with New Jersey reporting a rate of 1 in 41 compared with Maryland’s 1 in 123. SOURCES: U.S. Centers for Disease Control and Prevention / 31 Mar 2016 CDC estimates 1 in 68 school-aged children have autism; no change from previous estimate http://www.cdc.gov/media/releases/2016/p0331-children-autism.html Film flub First it was on, then it was off. Now it’s back on again. “Vaxxed: From Cover-Up to Catastrophe,” a film directed by the disbarred doctor Andrew Wakefield, will debut today at New York City’s Angelika Theater. 1 / 4 Spectrum | Autism Research News https://www.spectrumnews.org It’s not the venue the film’s makers had hoped for. “Vaxxed” was slated to premier at the prestigious Tribeca Film Festival, co-founded by actor Robert de Niro, who says he has a son with autism. -
Report on Bovine Herpesvirus 1 (BHV1)
Sanco/C3/AH/R20/2000 EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Scientific Opinions &ÃÃ0DQDJHPHQWÃRIÃVFLHQWLILFÃFRPPLWWHHVÃ,,ÃVFLHQWLILFÃFRRSHUDWLRQÃDQGÃQHWZRUNV 5HSRUWRQ %RYLQH+HUSHVYLUXV %+9 PDUNHUYDFFLQHV DQGWKHDFFRPSDQ\LQJ GLDJQRVWLFWHVWV 6FLHQWLILF&RPPLWWHHRQ$QLPDO+HDOWKDQG$QLPDO:HOIDUH $GRSWHG2FWREHU 5HSRUWRQ %RYLQH+HUSHVYLUXV %+9 PDUNHUYDFFLQHVDQGWKH DFFRPSDQ\LQJGLDJQRVWLFWHVWV 6FLHQWLILF&RPPLWWHHRQ$QLPDO+HDOWKDQG$QLPDO:HOIDUH 6&$+$: &RQWHQWV 5(48(67)25$123,1,21 ,1752'8&7,21$1'%$&.*5281' ',6&866,21211(:'$7$210$5.(59$&&,1(6$1'7+(,5,03/,&$7,216)25 %+9(5$',&$7,21 3.1. TYPES OF MARKER VACCINES AND THEIR POSSIBLE USE IN THE EUROPEAN UNION ..........................................3 3.2. EFFICACY OF MARKER VACCINES FOR USE IN ERADICATION PROGRAMMES ......................................................3 ([SHULPHQWDOVWXGLHV )LHOGWULDOV 'LVFXVVLRQDQGFRQFOXVLRQ 3.3 SAFETY, RISKS OF LATENCY, REACTIVATION, RE-EXCRETION, TRANSMISSION AND RECOMBINATION ASSOCIATED WITH THE USE OF LIVE MARKER VACCINES ............................................................................................7 ([SHULPHQWDOVWXGLHV 'LVFXVVLRQDQGFRQFOXVLRQ 3.4. QUALITY OF THE AVAILABLE ACCOMPANYING DIAGNOSTIC TESTS..................................................................9 7HVW6HQVLWLYLW\DQG6SHFLILFLW\ 5HSURGXFLELOLW\ 'LVFXVVLRQ 3.5 POSSIBILITY OF THE EXISTENCE OF SERONEGATIVE CARRIERS AND THE RISKS POSED.....................................11 ([SHULPHQWDOGDWD 'LVFXVVLRQDQGFRQFOXVLRQ *(1(5$/&21&/86,21 -
A Decade of Research Into Classical Swine Fever
Blome et al. Vet Res (2017) 48:51 DOI 10.1186/s13567-017-0457-y REVIEW Open Access A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine properties Sandra Blome*, Kerstin Wernike, Ilona Reimann, Patricia König, Claudia Moß and Martin Beer Abstract Due to its impact on animal health and pig industry, classical swine fever (CSF) is still one of the most important viral diseases of pigs. To control the disease, safe and highly efcacious live attenuated vaccines exist for decades. However, until recently, the available live vaccines did not allow a serological marker concept that is essentially important to circumvent long-term trade restrictions. In 2014, a new live attenuated marker vaccine, Suvaxyn ® CSF Marker (Zoetis), was licensed by the European Medicines Agency. This vaccine is based on pestivirus chimera “CP7_E2alf” that car- ries the main immunogen of CSF virus “Alfort/187”, glycoprotein E2, in a bovine viral diarrhea virus type 1 backbone (“CP7”). This review summarizes the available data on design, safety, efcacy, marker diagnostics, and its possible integration into control strategies. Table of contents in either endemic situations or in case of large, high- 1 Introduction impact contingencies, safe and highly efcacious live 2 Design and manufacturing attenuated vaccines exist for decades [50]. Te under- lying virus strains (e.g. the C-strain of CSFV or the 3 Genetic stability guinea-pig exaltation negative GPE−-strain) were 4 Safety and vaccine virus distribution attenuated through serial passages in either animals 5 Efcacy (rabbits) or cell culture, and have been implemented 6 Diva as part of mandatory control programs that led to the 6.1 Genetic DIVA eradication of CSF from several countries [19]. -
Dissemination of Vaccine Misinformation on Twitter and Its Countermeasures
Dissertation Dissemination of Vaccine Misinformation on Twitter and Its Countermeasures Christine Chen This document was submitted as a dissertation in March 2021 in partial fulfillment of the requirements of the doctoral degree in public policy analysis at the Pardee RAND Graduate School. The faculty committee that supervised and approved the dissertation consisted of Luke Matthews (Chair), Sarah Nowak and Jeremy Miles. The external reader was Jennifer Golbeck. This dissertation was generously supported by the Anne and James Rothenberg Dissertation Award. PARDEE RAND GRADUATE SCHOOL For more information on this publication, visit http://www.rand.org/pubs/rgs_dissertations/RGSDA1332-1.html Published 2021 by the RAND Corporation, Santa Monica, Calif. is a registered trademarK Limited Print and Electronic Distribution Rights This document and trademarK(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited. Permission is given to duplicate this document for personal use only, as long as it is unaltered and complete. Permission is reQuired from RAND to reproduce, or reuse in another form, any of its research documents for commercial use. For information on reprint and linking permissions, please visit www.rand.org/pubs/permissions.html. The RAND Corporation is a research organization that develops solutions to public policy challenges to help maKe communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest. RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors. Support RAND MaKe a tax-deductible charitable contribution at www.rand.org/giving/contribute www.rand.org Abstract Outbreaks of vaccine preventable diseases have continued to affect many parts of the United States. -
Pennington to Lead Student Body
PAGE 2 • NEWS PAGE 7 • ARTS PAGE 16 • FEATURES During hybrid learning, Head designer of the Check out reviews of three many teachers have sneaker shop Leaders chicken sandwiches from struggled to find a 1354, alumnus Ellen Ma around Chicago. Find balance where both in- uses her platform to out how factors such as person and distance connect Asian and Black presentation, freshness, learning students remain communities in Chicago crispiness and flavor can engaged in class. through streetwear. make or break the taste. University of Chicago Laboratory High School 1362 East 59th Street, Chicago,U-HIGH Illinois 60637 MIDWAY uhighmidway.com • Volume 97, Number 2 MAY 6, 2021 Editors Pennington to lead student body by AMANDA CASSEL With a relatively low voter EDITOR-IN-CHIEF 2021-22 Student Council turnout this year, do you think sign off This interview took place May 1, Student Council is representative President: Brent Pennington the day after the election, and was of the entire student body? Kennedi Bickham lightly edited for clarity and space. Vice President: Student Council is 23 people year of The extended version is online. Secretary: Peter Stern representing 610 students. There What is your main goal or a Treasurer: Taig Singh is no way in the world that Student couple of your main goals as all- Cultural Union President: Council is going to be able to rep- distance school president. How do you Saul Arnow resent that many people with just plan to put them into action? Cultural Union Vice President: 23 people, which is why I want to by EDITORS-IN-CHIEF My main goal as all-school pres- make sure that Student Council is Katie Baffa Dear Readers, ident is to make it so that Student open to having people who either Fourteen months ago, life Council is capable of accomplish- CLASS OF 2022 didn’t win or just didn’t run at all to changed: from classes to ing a lot and to prove to the rest of President: Zachary Gin come on Student Council and rep- clubs to sports. -
Vaxxed: from Cover-Up to Catastrophe (2016) Information for Parents
Vaxxed: From Cover-up to Catastrophe (2016) Information for parents Vaxxed is a 90 minute film that claims the measles-mumps-rubella (MMR) vaccine is responsible for a rise in children developing autism. It says the Centers for Disease Control (CDC) in the United States had evidence of this link and destroyed the data. A researcher, Brian Hooker, is featured in the film talking about how he re-analysed the CDC data and ‘discovered’ the link the CDC tried to hide. There is no scientific basis to the claims made by this film. The MMR vaccine is considered an extremely safe and effective vaccine that protects children and our community from significant and potentially serious illness caused by measles, mumps and rubella diseases. Key points • When public confidence in the MMR vaccine wavered in • Vaxxed is written and directed by the discredited former the 1990s, MMR immunisation rates dropped and measles gastroenterologist Andrew Wakefield. It appears to be an cases increased, leading to many children being hospitalised attempt to stir up fear against the MMR vaccine. Wakefield and some deaths from measles. The number of children has a patent for a measles-only vaccine. diagnosed with autism over this time increased. • The background to this film begins in 1998. A small research • Protecting children by immunising them with the MMR study by Andrew Wakefield and colleagues appeared in a vaccine is by far the safest option to prevent measles, medical journal. This study involved just 12 children and mumps, and rubella and the associated illness and was later shown to have used data obtained using unethical complications. -
Farm-Vaccine-Long.Pdf
GUIDELINES Responsible use of vaccines and vaccinations in farm animal production A farm health planning initiative in partnership with DEFRA Supported by the National Office of Animal Health (NOAH) November 2006 CONTENTS Page No. CONTENTS........................................................................................................................1 INTRODUCTION.............................................................................................................. 3 THE MECHANISMS OF INFECTION AND IMMUNITY ......................................... 4 Defence Mechanisms.......................................................................................................... 4 IMMUNITY........................................................................................................................5 Humoral (or [Blood] Circulating) Immunity .................................................................. 6 Cell Mediated Immunity (CMI) ....................................................................................... 7 THE OBJECTIVES OF VACCINATION ...................................................................... 8 TYPES OF ANTIBODY.................................................................................................... 8 THE PROCESS OF PRODUCING AN IMMUNE RESPONSE.................................. 8 Vaccines ............................................................................................................................ 10 Reactivation of the Immune Response.......................................................................... -
Press Release
Press Release Vermont Coalition for Vaccine Choice Contact: Beverly Stone Telephone: (802) 490 2373 Email: [email protected] VAXXED: From Cover-up to Catastrophe to Be Shown in Vermont Theaters October 18, 2016 - BRATTLEBORO, VT — The controversial documentary film “VAXXED: From Cover-up to Catastrophe” will be screened at the Latchis Theater in Brattleboro, Vermont on Monday, October 24th at 7 p.m. Tickets ($11) are available through Eventbrite at: tinyurl.com/jb8uswb. “VAXXED” presents a whistleblower from within the U.S. government and investigates how the Centers for Disease Control and Prevention (CDC) concealed and destroyed data they had in their possession that showed a link between the MMR (measles, mumps and rubella) vaccine and autism. CDC is the national agency charged with protecting the public health and autism is potentially the most catastrophic epidemic of our lifetime, affecting 1 in every 68 children today. VAXXED captured international headlines when it was pulled from the already- announced line-up of the Tribeca Film Festival under pressure from festival sponsors. Two weeks later, on national television (NBC’s Today Show), festival co-founder Robert De Niro, who has a son with autism, said: "There's something there that people aren't addressing… All I wanted is the movie to be seen. People can make their own judgment, but you must see it." Since being banned from Tribeca, VAXXED has been screened in 65 cities and 29 states and is on track to become the largest crowd-sourced theatrical campaign of all time. The film is produced by Polly Tommey of the Autism Media Channel and Del Bigtree, formerly a producer of the hit show “The Doctors.” The film is directed by Dr. -
A Critical Review About Different Vaccines Against Classical Swine Fever Virus and Their Repercussions in Endemic Regions
Review A Critical Review about Different Vaccines against Classical Swine Fever Virus and Their Repercussions in Endemic Regions Liani Coronado 1, Carmen L. Perera 1, Liliam Rios 2, María T. Frías 1 and Lester J. Pérez 3,*,† 1 National Centre for Animal and Plant Health (CENSA), OIE Collaborating Centre for Disaster Risk Reduction in Animal Health, San José de las Lajas 32700, Cuba; [email protected] (L.C.); [email protected] (C.L.P.); [email protected] (M.T.F.) 2 Reiman Cancer Research Laboratory, Faculty of Medicine, University of New Brunswick, Saint John, NB E2L 4L5, Canada; [email protected] 3 Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois at Urbana–Champaign, Champaign, IL 61802, USA * Correspondence: [email protected] † New Affiliation: Virus Discovery Group, Abbott Diagnostics, Abbott Park, IL 60064, USA. Abstract: Classical swine fever (CSF) is, without any doubt, one of the most devasting viral infec- tious diseases affecting the members of Suidae family, which causes a severe impact on the global economy. The reemergence of CSF virus (CSFV) in several countries in America, Asia, and sporadic outbreaks in Europe, sheds light about the serious concern that a potential global reemergence of this disease represents. The negative aspects related with the application of mass stamping out policies, including elevated costs and ethical issues, point out vaccination as the main control measure against future outbreaks. Hence, it is imperative for the scientific community to continue with the active Citation: Coronado, L.; Perera, C.L.; investigations for more effective vaccines against CSFV.